Nucleic acid encoding recombinant interferon
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 8, 2009
Grant Date -
Aug 4, 2005
app pub date -
Aug 26, 2004
filing date -
Aug 28, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention provides a recombinant super-compound interferon or an equivalent thereof with changed spatial configuration. The super-compound interferon possesses anti-viral or anti-tumor activity and, therefore, is useful in preventing and treating viral diseases and cancers. This invention also provides an artificial gene which codes for the super-compound interferon or its equivalent. Finally, this invention provides methods for producing recombinant super-compound interferon or its equivalent and various uses of said interferon.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully